Page last updated: 2024-11-04

sulfasalazine and Movement Disorders

sulfasalazine has been researched along with Movement Disorders in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engel, WK1
Dorman, JD1
Levy, RI1
Fredrickson, DS1

Other Studies

1 other study available for sulfasalazine and Movement Disorders

ArticleYear
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage.
    Archives of neurology, 1967, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Blood Chemical Analysis; Bone Marrow; Bone Marrow Cells; Cholesterol; Chromatogra

1967